✦ LIBER ✦

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

✍ Scribed by David I. Marks; Antonio Pagliuca; Christopher C. Kibbler; Axel Glasmacher; Claus-Peter Heussel; Michal Kantecki; Paul J.S. Miller; Patricia Ribaud; Haran T. Schlamm; Carlos Solano; Gordon Cook; for the IMPROVIT Study Group

Book ID: 108677413
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 171 KB
Volume: 155
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08838.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of micafungin versus fluconazole for

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

✍ Yasushi Hiramatsu; Yoshinobu Maeda; Nobuharu Fujii; Takashi Saito; Yuichiro Nawa 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

High frequencies of CD62L+ naive regulat

High frequencies of CD62L+ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation

✍ S-Y. Lu; K-Y. Liu; D-H. Liu; L-P. Xu; X-J. Huang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 968 KB

Successful neutrophil engraftment by red

Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis

✍ Atsuo Okamura; Kimikazu Yakushijin; Yumiko Inui; Yohei Funakoshi; Yuriko Kawamor 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 233 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat